Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans

Carcinogenesis

Volumn 34, Issue 1, 2013, Pages 113-120

  Tang, Deliang ^a   Kryvenko, Oleksandr N ^b   Wang, Yun ^b   Jankowski, Michelle ^b   Trudeau, Sheri ^b   Rundle, Andrew ^a   Rybicki, Benjamin A ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER GRADING; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA ADDUCT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; DNA ADDUCTS; HUMANS; MALE; MIDDLE AGED; POLYCYCLIC COMPOUNDS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 84872165068     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs326     Document Type: Article

References (58)

1. Jemal, A. et al. (2010) Declining death rates reflect progress against cancer. PLoS ONE, 5, e9584.
2. Jemal, A. et al. (2010) Cancer statistics, 2010. CA. Cancer J. Clin., 60, 277-300.
3. Haiman, C.A. et al. (2011) Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat. Genet., 43, 570-573.
4. Kwabi-Addo, B. et al. (2010) Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clin. Cancer Res., 16, 3539-3547.
5. Powell, I.J. et al. (2010) Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J. Urol., 183, 1792-1796.
6. Hatcher, D. et al. (2009) Molecular mechanisms involving prostate cancer racial disparity. Am. J. Transl. Res., 1, 235-248.
7. Freedland, S.J. et al. (2005) Explaining racial differences in prostate cancer in the United States: sociology or biology? Prostate, 62, 243-252.
8. Yu, M.C. et al. (1995) Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers. Cancer Epidemiol. Biomarkers Prev., 4, 861-864.
9. Relling, M.V. et al. (1992) Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin. Pharmacol. Ther., 52, 643-658.
10. Muscat, J.E. et al. (2008) Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers. Biochem. Pharmacol., 76, 929-937.
11. Trzeciak, A.R. et al. (2008) Age, sex, and race influence single-strand break repair capacity in a human population. Free Radic. Biol. Med., 45, 1631-1641.
12. Yang, SK & Silverman, BD. (1988) Polycyclic Aromatic Hydrocarbon Carcinogenesis: Structure-activity Relationships. CRC Press, Boca Raton.
13. Aronson, K.J. et al. (1996) Occupational risk factors for prostate cancer: results from a case-control study in Montréal, Québec, Canada. Am. J. Epidemiol., 143, 363-373.
14. Brown, D.A. et al. (2000) Motor vehicle manufacturing and prostate cancer. Am. J. Ind. Med., 38, 59-70.
15. Sinha, R. et al. (2009) Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States. Am. J. Epidemiol., 170, 1165-1177.
16. Punnen, S. et al. (2011) Impact of meat consumption, preparation, and mutagens on aggressive prostate cancer. PLoS ONE, 6, e27711.
17. Wang, C.Y. et al. (1999) N-Acetyltransferase expression and DNA binding of N-hydroxyheterocyclic amines in human prostate epithelium. Carcinogenesis, 20, 1591-1595.
18. Williams, J.A. et al. (2000) Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue. Carcinogenesis, 21, 1683-1689.
19. Kooiman, G.G. et al. (2000) The influence of dietary and environmental factors on prostate cancer risk. Prostate Cancer Prostatic Dis., 3, 256-258.
20. Miller, E.C. et al. (1981) Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer, 47, 2327-2345.
21. Pratt, M.M. et al. (2011) Polycyclic aromatic hydrocarbon (PAH) exposure and DNA adduct semi-quantitation in archived human tissues. Int. J. Environ. Res. Public Health, 8, 2675-2691.
22. Rybicki, B.A. et al. (2004) Polycyclic aromatic hydrocarbon-DNA adducts in prostate cancer. Cancer Res., 64, 8854-8859.
23. Nock, N.L. et al. (2007) Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race. Cancer Epidemiol. Biomarkers Prev., 16, 1236-1245.
24. Rybicki, B.A. et al. (2008) Polycyclic aromatic hydrocarbon-DNA adducts in prostate and biochemical recurrence after prostatectomy. Clin. Cancer Res., 14, 750-757.
25. Ketelslegers, H.B. et al. (2006) Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphisms in smokers. Cancer Epidemiol. Biomarkers Prev., 15, 624-629.
26. Pratt, M.M. et al. (2007) The importance of carcinogen dose in chemoprevention studies: quantitative interrelationships between, dibenzo[a, l]pyrene dose, chlorophyllin dose, target organ DNA adduct biomarkers and final tumor outcome. Carcinogenesis, 28, 611-624.
27. Rundle, A. et al. (2000) The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis, 21, 1281-1289.
28. Peluso, M. et al. (2005) DNA adducts and lung cancer risk: a prospective study. Cancer Res., 65, 8042-8048.
29. Tang, D. et al. (2001) Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res., 61, 6708-6712.
30. Gunter, M.J. et al. (2007) Leukocyte polycyclic aromatic hydrocarbon-DNA adduct formation and colorectal adenoma. Carcinogenesis, 28, 1426-1429.
31. Agudo, A. et al. (2012) Aromatic DNA adducts and risk of gastrointestinal cancers: a case-cohort study within the EPIC-Spain. Cancer Epidemiol. Biomarkers Prev., 21, 685-692.
32. Chen, S.Y. et al. (2002) Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int. J. Cancer, 99, 14-21.
33. Peluso, M. et al. (1998) White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev., 7, 341-346.
34. Benhamou, S. et al. (2003) DNA adducts in normal bladder tissue and bladder cancer risk. Mutagenesis, 18, 445-448.
35. Marjani, H.A. et al. (2010) Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from Iran. Genet. Mol. Res., 9, 239-249.
36. Kryvenko, O.N. et al. (2012) Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer. Mod. Pathol., 25, 1023-1032.
37. Zhang, Y.J. et al. (1995) Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in oral mucosa cells of smokers and nonsmokers. Cancer Epidemiol. Biomarkers Prev., 4, 133-138.
38. Zenzes, M.T. et al. (1998) Immunodetection of benzo[a]pyrene adducts in ovarian cells of women exposed to cigarette smoke. Mol. Hum. Reprod., 4, 159-165.
39. Kriek, E. et al. (1998) Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat. Res., 400, 215-231.
40. Gammon, M.D. et al. (2002) Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol. Biomarkers Prev., 11, 677-685.
41. van Schooten, F.J. et al. (1992) Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung. Carcinogenesis, 13, 987-993.
42. Wiencke, J.K. et al. (1995) Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. Cancer Res., 55, 4910-4914.
43. Nesnow, S. et al. (1993) Quantitative and temporal relationships between DNA adduct formation in target and surrogate tissues: implications for biomonitoring. Environ. Health Perspect., 101 (suppl. 3), 37-42.
44. Powell, I.J. (2007) Epidemiology and pathophysiology of prostate cancer in African-American men. J. Urol., 177, 444-449.
45. Merrill, R.M. et al. (2000) Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology, 55, 730-735.
46. Weiserbs, K.F. et al. (2003) A cross-sectional study of polycyclic aromatic hydrocarbon-DNA adducts and polymorphism of glutathione S-transferases among heavy smokers by race/ethnicity. Biomarkers, 8, 142-155.
47. Wang, S. et al. (2008) Assessment of interactions between PAH exposure and genetic polymorphisms on PAH-DNA adducts in African American, Dominican, and Caucasian mothers and newborns. Cancer Epidemiol. Biomarkers Prev., 17, 405-413.
48. Caraballo, R.S. et al. (1998) Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. JAMA, 280, 135-139.
49. Benowitz, N.L. et al. (2011) Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure. Nicotine Tob. Res., 13, 772-783.
50. Sørensen, M. et al. (2003) Linking exposure to environmental pollutants with biological effects. Mutat. Res., 544, 255-271.
51. De Marzo, A.M. et al. (2007) Inflammation in prostate carcinogenesis. Nat. Rev. Cancer, 7, 256-269.
52. Santella, R.M. (1999) Immunological methods for detection of carcinogen-DNA damage in humans. Cancer Epidemiol. Biomarkers Prev., 8, 733-739.
53. Mumford, J.L. et al. (1996) A sensitive color ELISA for detecting polycyclic aromatic hydrocarbon-DNA adducts in human tissues. Mutat. Res., 359, 171-177.
54. Gyorffy, E. et al. (2004) DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and nonsmoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay. Carcinogenesis, 25, 1201-1209.
55. Rundle, A. et al. (2012) Neighborhood socioeconomic status modifies the association between individual smoking status and PAH-DNA adduct levels in prostate tissue. Environ. Mol. Mutagen., 53, 384-391.
56. Nock, N.L. et al. (2006) Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk. Cancer Epidemiol. Biomarkers Prev., 15, 756-761.
57. Hu, J.J. et al. (2004) Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res., 64, 1197-1201.
58. Rundle, A. et al. (2003) Issues in the epidemiological analysis and interpretation of intermediate biomarkers. Cancer Epidemiol. Biomarkers Prev., 12, 491-496.